IPO Trending
NEPHROPLUSEQ / NSE, BSEListed

Nephrocare Health Services Limited

Incorporated in 2010, Nephrocare Health Services Ltd. provides comprehensive dialysis care through an extensive network of clinics across India and select international markets. As of March 31, 2025, the company operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal—including the world’s largest dialysis clinic in Uzbekistan. Nephrocare serves 269 cities across 21 states and 4 union territories, with nearly 77% of its centers located in tier II and III regions to improve access for underserved populations. In FY 2025, it treated 29,281 patients and delivered over 2.88 million dialysis sessions, representing about 10% of India’s dialysis patient base. The company managed 5,068 dialysis machines by March 2025, demonstrating consistent growth over prior years. Nephrocare has also partnered with leading hospital chains such as Max, Fortis Escorts, Care Hospitals, Wockhardt, Paras, CMRI, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers and enhance service reach.

₹438 - ₹46014.08x sub
Listed Price491.70
Listing Gain+6.89%
Review-Analyst Consensus Verdict

Not Rated

Axis Capital recommendation is Not Rated.

Apply
571%
May Apply
114%
Neutral
00%
Avoid
00%
Not Rated
114%
Brokers / Analysts Review
ReviewerRecommendationReport
Axis CapitalNot RatedDownload
Kunvarji Finstock Pvt LtdApplyDownload
Lakshmishree Investment & Securities LimitedApplyDownload
Capital MarketMay ApplyDownload
SBICAP Securities LimitedApplyDownload
SMIFS LimitedApplyDownload
Swastika Investmart LtdApplyDownload